+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Brinzolamide"

Antiglaucoma Drugs Market Report 2025 - Product Thumbnail Image

Antiglaucoma Drugs Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
From
Glaucoma Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Glaucoma Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • February 2024
  • 360 Pages
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Brinzolamide is a carbonic anhydrase inhibitor used to treat ocular hypertension and glaucoma. It is a topical ophthalmic solution that works by decreasing the amount of fluid in the eye, thereby reducing intraocular pressure. It is often used in combination with other medications to treat glaucoma. Brinzolamide is available in both generic and brand-name formulations. Common side effects include stinging, burning, and redness of the eyes. Brinzolamide is a key component of the optical disorders drugs market. It is used to treat a variety of ocular conditions, including glaucoma, ocular hypertension, and uveitis. It is also used to reduce the risk of vision loss in patients with glaucoma. Brinzolamide is a cost-effective treatment option for many patients, as it is available in both generic and brand-name formulations. Some companies in the Brinzolamide market include Alcon, Allergan, Bausch + Lomb, and Santen Pharmaceuticals. Show Less Read more